Teligent, Inc. has revealed that the US Food and Drug Administration has commenced an “earlier than anticipated” current good manufacturing practices inspection and reinspection of the company’s key manufacturing facility in Buena New Jersey, to follow up on warning letter remediation action that was initiated in mid-July.
“Our Buena manufacturing facility represents a major investment into expanding our manufacturing capabilities,” said Tim Sawyer, president and CEO of...




